GIV/girdin is a rheostat that fine-tunes growth factor signals during tumor progression

Cell Adhesion and Migration

Volumn 5, Issue 3, 2011, Pages

  Ghosh, Pradipta ^a   Garcia Marcos, Mikel ^b   Farquhar, Marilyn G ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Actin cytoskeleton; Akt; Alternative splicing; Epidermal growth factor receptor; G protein coupled receptors; G proteins; Girdin; Growth factors; Guanine nucleotide exchange factor; Metastasis; Migration proliferation dichotomy; PI3 kinase; Rheostat

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GIRDIN PROTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CCDC88A PROTEIN, HUMAN; G PROTEIN COUPLED RECEPTOR; VESICULAR TRANSPORT PROTEIN;

ANGIOGENESIS; AUTOPHOSPHORYLATION; BIOINFORMATICS; CANCER CELL; CANCER INVASION; CANCER STEM CELL; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM; EPITHELIUM; METASTASIS; MUTAGENESIS; NONHUMAN; NOTE; PHENOTYPE; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY;

GREAT ISLAND VIRUS;

ANIMALS; HUMANS; MICROFILAMENT PROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; VESICULAR TRANSPORT PROTEINS;

EID: 85046980000     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.5.3.15909     Document Type: Note

References (100)

1. Le-Niculescu H, Niesman I, Fischer T, DeVries L, Farquhar MG. Identification and characterization of GIV, a novel Galpha i/s-interacting protein found on COPI, endoplasmic reticulum-Golgi transport vesicles. J Biol Chem 2005; 280:22012-20. (Pubitemid 40827855)
2. Simpson F, Martin S, Evans TM, Kerr M, James DE, Parton RG, et al. A novel hook-related protein family and the characterization of hook-related protein 1. Traffic 2005; 6:442-58. (Pubitemid 40740385)
3. Anai M, Shojima N, Katagiri H, Ogihara T, Sakoda H, Onishi Y, et al. A novel protein kinase B (PKB)/AKT-binding protein enhances PKB kinase activity and regulates DNA synthesis. J Biol Chem 2005; 280:18525-35. (Pubitemid 41389103)
4. Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, et al. Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 2005; 9:389-402. (Pubitemid 41235808)
5. Enomoto A, Ping J, Takahashi M. Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways. Ann NY Acad Sci 2006; 1086:169-84. (Pubitemid 47084384)
6. Ghosh P, Garcia-Marcos M, Bornheimer SJ, Farquhar MG. Activation of Galphai3 triggers cell migration via regulation of GIV. J Cell Biol 2008; 182:381-93.
7. Garcia-Marcos M, Ghosh P, Farquhar MG. GIV is a nonreceptor GEF for Galphai with a unique motif that regulates Akt signaling. Proc Natl Acad Sci USA 2009; 106:3178-83.
8. Jiang P, Enomoto A, Jijiwa M, Kato T, Hasegawa T, Ishida M, et al. An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res 2008; 68:1310-8. (Pubitemid 351346837)
9. Kitamura T, Asai N, Enomoto A, Maeda K, Kato T, Ishida M, et al. Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat Cell Biol 2008; 10:329-37. (Pubitemid 351331020)
10. Garcia-Marcos M, Ghosh P, Ear J, Farquhar MG. A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration. J Biol Chem 2010; 285:12765-77.
11. Maier U, Babich A, Nurnberg B. Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide-3-kinase isoforms beta and gamma. J Biol Chem 1999; 274:29311-7.
12. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, Hawkins PT. A novel phosphoinositide-3-kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. Cell 1994; 77:83-93. (Pubitemid 24184690)
13. Garcia-Marcos M, Jung BH, Ear J, Cabrera B, Carethers JM, Ghosh P. Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer. FASEB J 2011; 25:590-9.
14. Ghosh P, Beas AO, Bornheimer SJ, Garcia-Marcos M, Forry EP, Johannson C, et al. A Gi-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell 2010; 21:2338-54.
15. Weng L, Enomoto A, Ishida-Takagishi M, Asai N, Takahashi M. Girding for migratory cues: roles of the Akt substrate Girdin in cancer progression and angiogenesis. Cancer Sci 2010.
16. Haugh JM. Localization of receptor-mediated signal transduction pathways: the inside story. Mol Interv 2002; 2:292-307.
17. Rijken PJ, Hage WJ, van Bergen en Henegouwen PM, Verkleij AJ, Boonstra J. Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells. J Cell Sci 1991; 100:491-9.
18. Iyer AK, Tran KT, Griffith L, Wells A. Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling. J Cell Physiol 2008; 214:504-12. (Pubitemid 350309007)
19. Howlin J, Rosenkvist J, Andersson T. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res 2008; 10:36.
20. Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, Bunnett NW. Endosomes: a legitimate platform for the signaling train. Proc Natl Acad Sci USA 2009; 106:17615-22.
21. Athale C, Mansury Y, Deisboeck TS. Simulating the impact of a molecular 'decision-process' on cellular phenotype and multicellular patterns in brain tumors. J Theor Biol 2005; 233:469-81.
22. Chen P, Xie H, Sekar MC, Gupta K, Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 1994; 127:847-57. (Pubitemid 24332978)
23. Cho H, Kehrl JH. Localization of Gi alpha proteins in the centrosomes and at the midbody: implication for their role in cell division. J Cell Biol 2007; 178:245-55. (Pubitemid 47076461)
24. Fedotov S, Iomin A. Migration and proliferation dichotomy in tumor-cell invasion. Phys Rev Lett 2007; 98:118101.
25. Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME. Dichotomy of astrocytoma migration and proliferation. Int J Cancer 1996; 67:275-82. (Pubitemid 26274161)
26. Bonneton C, Sibarita JB, Thiery JP. Relationship between cell migration and cell cycle during the initiation of epithelial to fibroblastoid transition. Cell Motil Cytoskeleton 1999; 43:288-95. (Pubitemid 29368202)
27. Chung EH, Hutcheon AE, Joyce NC, Zieske JD. Synchronization of the G1/S transition in response to corneal debridement. Invest Ophthalmol Vis Sci 1999; 40:1952-8. (Pubitemid 29365157)
28. Gaylarde PM, Sarkany I. Cell migration and DNA synthesis in organ culture of human skin. Br J Dermatol 1975; 92:375-80.
29. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977; 14:53-65. (Pubitemid 8153798)
30. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161:1163-77. (Pubitemid 36870177)
31. Mandel HG, Rall DP. The present status of cancer chemotherapy - a summary of papers delivered at the Cherry Hill Conference on "a critical evaluation of cancer chemotherapy". Cancer Res 1969; 29:2478-85.
32. Schlessinger J, Lemmon MA. SH2 and PTB domains in tyrosine kinase signaling. Sci STKE 2003; 2003:12.
33. Shao H, Wu C, Wells A. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. J Biol Chem 285:2591-600.
34. Tang J, Gross DJ. Regulated EGF receptor binding to F-actin modulates receptor phosphorylation. Biochem Biophys Res Commun 2003; 312:930-6. (Pubitemid 37490905)
35. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747-52.
36. Becker M, Sommer A, Kratzschmar JR, Seidel H, Pohlenz HD, Fichtner I. Distinct gene expression patterns in a tamoxifen-sensitive human mammary carcinoma xenograft and its tamoxifen-resistant subline MaCa 3366/TAM. Mol Cancer Ther 2005; 4:151-68. (Pubitemid 40268073)
37. Nagaraja GM, Othman M, Fox BP, Alsaber R, Pellegrino CM, Zeng Y, et al. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 2006; 25:2328-38.
38. Stickeler E, Kittrell F, Medina D, Berget SM. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 1999; 18:3574-82. (Pubitemid 29322382)
39. Sassen S, Miska EA, Caldas C. MicroRNA: implications for cancer. Virchows Arch 2008; 452:1-10.
40. Godlewski J, Bronisz A, Nowicki MO, Chiocca EA, Lawler S. microRNA-451: A conditional switch controlling glioma cell proliferation and migration. Cell Cycle 9:2742-8.
41. Garcia-Marcos M, Ear J, Farquhar MG, Ghosh P. A GDI (AGS3) and a GEF (GIV) regulate autophagy by balancing G protein activity and growth factor signals. Mol Biol Cell 2011; 22:673-86.
42. Mehrpour M, Esclatine A, Beau I, Codogno P. Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am J Physiol Cell Physiol 298:776-85.
43. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003; 21:1624-36. (Pubitemid 46594118)
44. Oshita A, Kishida S, Kobayashi H, Michiue T, Asahara T, Asashima M, et al. Identification and characterization of a novel Dvl-binding protein that suppresses Wnt signalling pathway. Genes Cells 2003; 8:1005-17. (Pubitemid 38072276)
45. Matsushita E, Asai N, Enomoto A, Kawamoto Y, Kato T, Mii S, et al. Protective role of Gipie, a Girdin family protein, in endoplasmic reticulum stress responses in endothelial cells. Mol Biol Cell 22:736-47.
46. Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987; 56:615-49.
47. Cao C, Huang X, Han Y, Wan Y, Birnbaumer L, Feng GS, et al. Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal 2009; 2:17.
48. Dhanasekaran DN. Transducing the signals: a G protein takes a new identity. Sci STKE 2006; 2006:31.
49. El-Shewy HM, Johnson KR, Lee MH, Jaffa AA, Obeid LM, Luttrell LM. Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors. J Biol Chem 2006; 281:31399-407. (Pubitemid 46041404)
50. Lanner MC, Raper M, Pratt WM, Rhoades RA. Heterotrimeric G proteins and the platelet-derived growth factor receptor-beta contribute to hypoxic proliferation of smooth muscle cells. Am J Respir Cell Mol Biol 2005; 33:412-9. (Pubitemid 41416293)
51. Zeng H, Zhao D, Yang S, Datta K, Mukhopadhyay D. Heterotrimeric Galphaq/Galpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling. J Biol Chem 2003; 278:20738-45. (Pubitemid 36806377)
52. Wang H, Ng KH, Qian H, Siderovski DP, Chia W, Yu F. Ric-8 controls Drosophila neural progenitor asymmetric division by regulating heterotrimeric G proteins. Nat Cell Biol 2005; 7:1091-8.
53. Thomas CJ, Tall GG, Adhikari A, Sprang SR. Ric-8A catalyzes guanine nucleotide exchange on G alphai1 bound to the GPR/GoLoco exchange inhibitor AGS3. J Biol Chem 2008; 283:23150-60.
54. Afshar K, Willard FS, Colombo K, Johnston CA, McCudden CR, Siderovski DP, et al. RIC-8 is required for GPR-1/2-dependent Galpha function during asymmetric division of C. elegans embryos. Cell 2004; 119:219-30. (Pubitemid 39360904)
55. Tall GG, Krumins AM, Gilman AG. Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. J Biol Chem 2003; 278:8356-62. (Pubitemid 36800584)
56. Bluthgen N, Bruggeman FJ, Legewie S, Herzel H, Westerhoff HV, Kholodenko BN. Effects of sequestration on signal transduction cascades. Febs J 2006; 273:895-906.
57. Ortega F, Acerenza L, Westerhoff HV, Mas F, Cascante M. Product dependence and bifunctionality compromise the ultrasensitivity of signal transduction cascades. Proc Natl Acad Sci USA 2002; 99:1170-5. (Pubitemid 34136465)
58. Thattai M, van Oudenaarden A. Attenuation of noise in ultrasensitive signaling cascades. Biophys J 2002; 82:2943-50. (Pubitemid 34547637)
59. Kholodenko BN, Sauro HM. Spatio-temporal dynamics of protein modification cascades. SEB Exp Biol Ser 2008; 61:141-59.
60. Sauro HM, Kholodenko BN. Quantitative analysis of signaling networks. Prog Biophys Mol Biol 2004; 86:5-43. (Pubitemid 38958526)
61. Liu Z, Kobayashi K, van Dinther M, van Heiningen SH, Valdimarsdottir G, van Laar T, et al. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression. J Cell Sci 2009; 122:3294-302.
62. Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, et al. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 2009; 284:28845-55.
63. Godt D, Tepass U. Breaking a temporal barrier: signalling crosstalk regulates the initiation of border cell migration. Nat Cell Biol 2009; 11:536-8.
64. + cells. J Leukoc Biol 2008; 84:1130-40.
65. Qiu L, Zhou C, Sun Y, Di W, Scheffler E, Healey S, et al. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int J Oncol 2006; 29:1003-11.
66. Zhang N, Oppenheim JJ. Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J Leukoc Biol 2005; 78:1210-4. (Pubitemid 41779226)
67. Eliceiri BP. Integrin and growth factor receptor crosstalk. Circ Res 2001; 89:1104-10. (Pubitemid 34627867)
68. Szabo I, Rogers TJ. Crosstalk between chemokine and opioid receptors results in downmodulation of cell migration. Adv Exp Med Biol 2001; 493:75-9. (Pubitemid 34020214)
69. Merlot S, Firtel RA. Leading the way: Directional sensing through phosphatidylinositol-3-kinase and other signaling pathways. J Cell Sci 2003; 116:3471-8. (Pubitemid 37063391)
70. Egloff AM, Rothstein ME, Seethala R, Siegfried JM, Grandis JR, Stabile LP. Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15:6529-40.
71. Teodorczyk M, Martin-Villalba A. Sensing invasion: Cell surface receptors driving spreading of glioblastoma. J Cell Physiol 2010; 222:1-10.
72. Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, et al. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer Res 2009; 69:1383-91.
73. Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM, et al. Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res 2008; 68:9712-22.
74. Shida D, Fang X, Kordula T, Takabe K, Lepine S, Alvarez SE, et al. Cross-talk between LPA1 and epidermal growth factor receptors mediates upregulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res 2008; 68:6569-77.
75. Thomas SM, Bhola NE, Zhang Q, Contrucci SC, Wentzel AL, Freilino ML, et al. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma. Cancer Res 2006; 66:11831-9. (Pubitemid 46094195)
76. Liu X, Lazenby AJ, Siegal GP. Signal transduction cross-talk during colorectal tumorigenesis. Adv Anat Pathol 2006; 13:270-4. (Pubitemid 44439982)
77. Even-Ram SC, Maoz M, Pokroy E, Reich R, Katz BZ, Gutwein P, et al. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alphavbeta5 integrin. J Biol Chem 2001; 276:10952-62. (Pubitemid 38089274)
78. Lauwaet T, Oliveira MJ, Mareel M, Leroy A. Molecular mechanisms of invasion by cancer cells, leukocytes and microorganisms. Microbes Infect 2000; 2:923-31. (Pubitemid 30483188)
79. Matsumoto K, Ziober BL, Yao CC, Kramer RH. Growth factor regulation of integrin-mediated cell motility. Cancer Metastasis Rev 1995; 14:205-17.
80. Bhogal RK, Stoica CM, McGaha TL, Bona CA. Molecular aspects of regulation of collagen gene expression in fibrosis. J Clin Immunol 2005; 25:592-603. (Pubitemid 43011750)
81. Bissell DM. Hepatic fibrosis as wound repair: a progress report. J Gastroenterol 1998; 33:295-302. (Pubitemid 28143414)
82. Novosyadlyy R, Dudas J, Pannem R, Ramadori G, Scharf JG. Crosstalk between PDGF and IGF-I receptors in rat liver myofibroblasts: implication for liver fibrogenesis. Lab Invest 2006; 86:710-23. (Pubitemid 43901668)
83. Uhal BD, Kim JK, Li X, Molina-Molina M. Angiotensin-TGFbeta1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr Pharm Des 2007; 13:1247-56. (Pubitemid 46739332)
84. Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goni S, Santamaria M, et al. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 2009; 234:713-25.
85. McCall-Culbreath KD, Li Z, Zutter MM. Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity. Blood 2008; 111:3562-70.
86. van der Veeken J, Oliveira S, Schiffelers RM, Storm G, van Bergen En Henegouwen PM, Roovers RC. Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy. Curr Cancer Drug Targets 2009; 9:748-60.
87. Vogel CF, Matsumura F. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NFkappaB family. Biochem Pharmacol 2009; 77:734-45.
88. Biggar SR, Crabtree GR. Cell signaling can direct either binary or graded transcriptional responses. EMBO J 2001; 20:3167-76. (Pubitemid 32612004)
89. Lachance JFB, Lomas MF, Eleiche A, Kerr PB, Nilson LA. Graded Egfr activity patterns the Drosophila eggshell independently of autocrine feedback. Development 2009; 136:2893-902.
90. Delfini MC, Dubrulle J, Malapert P, Chal J, Pourquie O. Control of the segmentation process by graded MAPK/ERK activation in the chick embryo. Proc Natl Acad Sci USA 2005; 102:11343-8. (Pubitemid 41153822)
91. Galindo MI, Bishop SA, Couso JP. Dynamic EGFR-Ras signalling in Drosophila leg development. Dev Dyn 2005; 233:1496-508. (Pubitemid 40995147)
92. Guner B, Ozacar AT, Thomas JE, Karlstrom RO. Graded hedgehog and fibroblast growth factor signaling independently regulate pituitary cell fates and help establish the pars distalis and pars intermedia of the zebrafish adenohypophysis. Endocrinology 2008; 149:4435-51.
93. Guzman-Ayala M, Lee KL, Mavrakis KJ, Goggolidou P, Norris DP, Episkopou V. Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells. PLoS One 2009; 4:4268.
94. Vincent SD, Dunn NR, Hayashi S, Norris DP, Robertson EJ. Cell fate decisions within the mouse organizer are governed by graded Nodal signals. Genes Dev 2003; 17:1646-62. (Pubitemid 36828791)
95. Xi R, McGregor JR, Harrison DA. A gradient of JAK pathway activity patterns the anterior-posterior axis of the follicular epithelium. Dev Cell 2003; 4:167-77. (Pubitemid 36221794)
96. Andersson J, Simpson DM, Qi M, Wang Y, Elion EA. Differential input by Ste5 scaffold and Msg5 phosphatase route a MAPK cascade to multiple outcomes. EMBO J 2004; 23:2564-76. (Pubitemid 38988228)
97. Elion EA. The Ste5p scaffold. J Cell Sci 2001; 114:3967-78. (Pubitemid 33115018)
98. Flatauer LJ, Zadeh SF, Bardwell L. Mitogen-activated protein kinases with distinct requirements for Ste5 scaffolding influence signaling specificity in Saccharomyces cerevisiae. Mol Cell Biol 2005; 25:1793-803. (Pubitemid 40280145)
99. Garrenton LS, Young SL, Thorner J. Function of the MAPK scaffold protein, Ste5, requires a cryptic PH domain. Genes Dev 2006; 20:1946-58. (Pubitemid 44079331)
100. Pincet F. Membrane recruitment of scaffold proteins drives specific signaling. PLoS One 2007; 2:977.